Showing results (2161-2170 of 2,348) with videos related to

Sort By:
Pageof 235
The AAPS Journal|June 18, 2021
Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect ModelsChristian Wagner, Filippos Kesisoglou, Xavier J H Pepin, et al.
The AAPS Journal|October 30, 2020
New Model-Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse SamplingFlorence Loingeville, Julie Bertrand, Thu Thuy Nguyen, et al.
The AAPS Journal|October 15, 2020
Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint InhibitorsOle Gjoerup, Charlotte A Brown, Jeffrey S Ross, et al.
The AAPS Journal|October 9, 2020
Simultaneous Ivabradine Parent-Metabolite PBPK/PD Modelling Using a Bayesian Estimation MethodJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
The AAPS Journal|December 28, 2020
Population Pharmacodynamic Modeling Using the Sigmoid Emax Model: Influence of Inter-individual Variability on the Steepness of the Concentration-Effect Relationship. a Simulation StudyJohannes H Proost, Douglas J Eleveld, Michel M R F Struys
The AAPS Journal|July 27, 2021
Exosomes in Atherosclerosis, a Double-Edged Sword: Their Role in Disease Pathogenesis and Their Potential as Novel TherapeuticsNeil Patel, Deborah D Chin, Eun Ji Chung
The AAPS Journal|May 1, 2008
The pharmacokinetics and interactions of ivermectin in humans--a mini-reviewAránzazu González Canga, Ana M Sahagún Prieto, M José Diez Liébana, et al.
The AAPS Journal|May 1, 2008
Pharmacokinetics of 1,4-butanediol in rats: bioactivation to gamma-hydroxybutyric acid, interaction with ethanol, and oral bioavailabilityHo-Leung Fung, Pei-Suen Tsou, Jurgen B Bulitta, et al.
The AAPS Journal|May 1, 2008
Rheological evaluation of silicon/carbopol hydrophilic gel systems as a vehicle for delivery of water insoluble drugsGiulia Bonacucina, Marco Cespi, Monica Misici-Falzi, et al.
The AAPS Journal|May 1, 2008
Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applicationsBarbara M Davit, Dale P Conner, Beth Fabian-Fritsch, et al.
Pageof 235